CochLear (OTCMKTS:CHEOY) Raised to "Strong-Buy" at Canaccord Genuity Group

Key Points

• Cochlear Limited was upgraded to a "strong-buy" rating by Canaccord Genuity Group, indicating increased analyst confidence in the stock.
• Currently, two analysts rate the stock as a Strong Buy while three others have assigned it a Hold rating, leading to an average rating of "Moderate Buy."
• As of recently, Cochlear's stock price opened at $94.18, with a twelve-month trading range between $74.76 and $105.60.

CochLear (OTCMKTS:CHEOY - Get Free Report) was upgraded by Canaccord Genuity Group from a "hold" rating to a "strong-buy" rating in a report issued on Tuesday,Zacks.com reports.

Several other research analysts have also recently weighed in on CHEOY. Zacks Research raised CochLear to a "hold" rating in a research report on Monday, August 11th. Citigroup cut shares of CochLear to a "neutral" rating in a research note on Thursday, September 18th. Finally, UBS Group upgraded CochLear from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, June 18th. Two research analysts have rated the stock with a Strong Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy".

CochLear Price Performance

CHEOY stock opened at $94.18 on Tuesday. The business's fifty day moving average is $98.10 and its 200-day moving average is $92.53. CochLear has a twelve month low of $74.76 and a twelve month high of $105.60.

About CochLear

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.